GlassScriptPhysician profile
Anne M Leger
NPI 1588957674
$10,051.01
in general payments reported to CMS, 2019-2025
35 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,550 · 2020: $645 · 2021: $834 · 2022: $1,933 · 2023: $2,078 · 2024: $1,690 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,911 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,910.87 |
| Education | $178.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,599.67 | 2019-2025 | |
| Galderma Laboratories, L.P. | $836.04 | 2019-2025 | Nemluvio, Aklief |
| Sun Pharmaceutical Industries INC. | $764.47 | 2019-2024 | Ilumya, Winlevi |
| Genzyme Corporation | $675.45 | 2019-2025 | |
| Lilly USA, LLC | $663.62 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $645.71 | 2019-2025 | |
| Janssen Biotech, INC. | $468.75 | 2020-2025 | Tremfya, Simponi, Simponi Aria |
| Leo Pharma INC. | $443.65 | 2019-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $413.60 | 2021-2025 | Dupixent |
| Merz North America, INC. | $374.55 | 2019-2022 | |
| Pfizer INC. | $349.32 | 2021-2025 | |
| Incyte Corporation | $223.99 | 2021-2024 | Opzelura |
| Ucb, INC. | $212.81 | 2019-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $210.01 | 2022-2025 | Sotyktu |
| Amgen INC. | $207.98 | 2022-2024 | Otezla |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $186.85 | 2020-2022 | |
| Allergan, INC. | $146.09 | 2019-2022 | |
| Biofrontera INC. | $90.43 | 2019-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Sanofi-Aventis U.S. LLC | $79.99 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $68.61 | 2019-2023 | Siliq |
| Dermavant Sciences, INC. | $61.71 | 2023-2024 | Vtama |
| Celgene Corporation | $56.75 | 2019 | |
| Almirall LLC | $38.53 | 2019-2023 | Seysara |
| Dermira, INC. | $31.01 | 2019 | |
| Fidia Pharma USA INC. | $25.57 | 2023 | Triluron, Hymovis |
| Arcutis Biotherapeutics, INC. | $24.53 | 2024 | Zoryve |
| Vyne Pharmaceuticals INC. | $24.35 | 2021 | |
| Journey Medical Corporation | $21.92 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.32 | 2019 | |
| Strata Skin Sciences, INC. | $17.75 | 2024 | Xtrac |
| Dusa Pharmaceuticals, INC. | $17.11 | 2019 | |
| Janssen Scientific Affairs, LLC | $13.77 | 2019 | |
| Encore Dermatology INC. | $13.14 | 2019 | |
| Promius Pharma LLC | $12.44 | 2019 | |
| Aclaris Therapeutics, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Leger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.